Maria A. Argiriadi
15Patents
6h-index
82Co-inventors
65Inventor score
Filing activity: Apr 2, 2007 → Aug 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008481B2 | Indazole compounds | Chemistry; Metallurgy | 107 | Active |
| US7915388B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 79 | Active |
| US8785639B2 | Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof | Chemistry; Metallurgy | 57 | Active |
| US8962629B2 | Tricyclic compounds | Chemistry; Metallurgy | 54 | Active |
| US9365579B2 | Tricyclic compounds | Chemistry; Metallurgy | 49 | Active |
| US9592293B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 16 | Active |
| US8604177B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US10086076B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US10508113B2 | Inhibitors of tyrosine kinase 2 mediated signaling | Chemistry; Metallurgy | 1 | Active |
| US11767310B2 | Nicotinamide RIPK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11344621B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US10160748B2 | Indazolones as modulators of tnf signaling | Chemistry; Metallurgy | 0 | Active |
| US10093733B2 | LRP-8 binding dual variable domain immunoglobulin proteins | Physics | 0 | Active |
| US9115151B2 | Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10106501B2 | Nuclear receptor modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.